May 1, 2024

May 2024 Provider Newsletter

Contents

AdministrativeCommercialMay 1, 2024

CAA: Maintain your online provider directory information

AdministrativeCommercialMay 1, 2024

Inaccurate laterality and diagnosis combination

Digital SolutionsCommercialMedicare AdvantageMedicaidMay 1, 2024

Roster automation update

Digital SolutionsCommercialApril 23, 2024

Overview of the Preference Center on Availity Essentials

Digital SolutionsMedicare AdvantageMay 1, 2024

Personalized Match update

Education & TrainingCommercialApril 25, 2024

Instructions for donor claim billing

Education & TrainingCommercialMedicare AdvantageMay 1, 2024

Rotary to ground educational message

Education & TrainingMedicaidMarch 31, 2023

Ready, set, renew!

Medical Policy & Clinical GuidelinesMedicaidApril 1, 2024

Clinical Criteria updates — December 2023

Products & ProgramsMedicaidMay 1, 2024

Bringing whole person care to sickle cell disease management

Federal Employee Program (FEP)CommercialMay 1, 2024

HEDIS tips: Adult Immunization Status (AIS-E)

PharmacyCommercialApril 24, 2024

Specialty pharmacy updates — May 2024

PharmacyMedicare AdvantageApril 8, 2024

Anthem expands specialty pharmacy precertification list

PharmacyCommercialApril 9, 2024

Acquisition of Paragon Healthcare

PharmacyCommercialMarch 1, 2024

Pharmacy information available on our provider website

KYBCBS-CDCRCM-056139-24

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

AdministrativeCommercialMedicare AdvantageMay 1, 2024

Carelon Post Acute Solutions, LLC will begin operating as Carelon Medical Benefits Management, Inc.

On April 1, 2024, Carelon Post Acute Solutions, LLC (formerly known as myNexus) began operating as Carelon Medical Benefits Management, Inc.

Provider materials that formerly included the Carelon Post Acute Solutions name, such as determination letters and provider forms, have adopted the new name. However, there will be no changes in the way you submit a case nor to the contact information you use for checking case status.

Please see below for a list of FAQ. Additional questions can be directed to our Health Care Networks team using the contact information below:

  • Home health providers: HHprovider_relations@carelon.com
  • Post-acute institutional management (PAC-IM) providers: PACprovider_relations@carelon.com
  • Durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) providers: DMEprovider_relations@carelon.com

Thank you for your continued partnership.

Carelon Medical Benefits Management transition FAQ

Q: Will there be any changes to the Carelon Post Acute Solutions provider website?

A: The name of our website has been updated to reflect Carelon Medical Benefits Management branding. Additionally, the web address you use today will automatically redirect to a new Carelon Medical Benefits Management site. There will be no changes to the case submission process.

Q: Are any phone number changes planned as part of this transition?

A: No, our inbound phone numbers will not change. The reference to Carelon Post Acute Solutions in recorded scripting will use the Carelon Medical Benefits Management name.

Q: How will third party websites, such as Availity, be impacted?

A: There will be no change to the way you access these websites. Within the sites, any reference to Carelon Post Acute Solutions will be replaced with the new name. This may take some time to fully complete.

Q: Will references to Carelon Post Acute Solutions on health plan websites and other materials be changed?

A: Yes, while you may continue to see the Carelon Post Acute Solutions company name on health plan websites for some time, these references will be updated over time through scheduled content update cycles. If your office includes the Carelon Post Acute Solutions name in any materials or web properties, we encourage you to update them to Carelon Medical Benefits Management during your next update cycle.

Q: Will information about Carelon Post Acute Solutions continue to be found on the corporate website?

A: Yes, post-acute care will be part of the Carelon Medical Benefits Management portfolio of solutions. You can learn more at careloninsights.com.

Q: Will provider resources, such as key documents and the provider finder, be impacted?

A: Our provider resources will continue to be available through our corporate website and our Provider Resources site.

Q: Does this impact provider agreements with Carelon Post Acute Solutions? Will I need to sign a new agreement?

A: No, there is no impact to provider agreements. You do not need to sign a new agreement regardless of whether your current contract is with MyNexus, Inc. or Carelon Post Acute Solutions.

Q: Do I need to complete credentialing again through Carelon Medical Benefits Management?

A: No, providers will not need to re-credential until their normal credentialing cycle.

Q: Will my claims be impacted?

A: No, claims are not impacted. Payer IDs will remain the same.

Q: Will I need to update my W-9?

A: Providers may need to update their W-9. If you need an updated W-9 from Carelon Medical Benefits Management, please contact the Carelon Provider Relations department at HHprovider_relations@carelon.com.

Carelon Post Acute Solutions, LLC is an independent company providing services on behalf of the health plan.
Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc., an independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-054832-24-CPN53974

AdministrativeCommercialMay 1, 2024

CAA: Maintain your online provider directory information

Maintaining your online provider directory information is essential for member and healthcare partners to connect with you when needed. Access your online provider directory information by visiting anthem.com/provider, then at the top of the webpage, choose Find Care. Review your information and let us know if any of your information we show in our online directory has changed.

Updating your information

Anthem uses the provider data management (PDM) capability available on Availity Essentials to update your provider or facility data. Using the Availity PDM capability meets the quarterly attestation requirement to validate provider demographic data set by the Consolidated Appropriations Act (CAA).

PDM features include:

  • Updating provider demographic information for all assigned payers in one location.
  • Attesting to and managing current provider demographic information.
  • Monitoring submitted demographic updates in real-time with a digital dashboard.
  • Reviewing the history of previously verified data.

Accessing the PDM application

Log on to Availity.com and select My Providers > Provider Data Management to begin using PDM. Administrators will automatically be granted access to PDM. Additional staff may be given access to PDM by an administrator. To find your administrator, go to My Account Dashboard > My Account > Organization(s) > Administrator Information.

PDM training

PDM training is available:

  • Learn about and attend one of our training opportunities by visiting here.
  • View the Availity PDM quick start guide here.
  • For Roster Automation Standard Template and Roster Automation Rules of Engagement specific training, listen to our recorded webinar here.

Not registered for Availity yet?

If you aren’t registered to use Availity Essentials, signing up is easy and 100% secure. There is no cost for your providers to register or to use any of our digital applications. Start by going to Availity.com and selecting New to Availity? Get Started at the top of the home screen to access the registration page. If you have more than one tax ID number (TIN), please ensure you have registered all TINs associated with your account.

If you have questions regarding registration, reach out to Availity Client Services at 800-AVAILITY.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-056357-24-CPN55995

AdministrativeCommercialMay 1, 2024

Inaccurate laterality and diagnosis combination

Providers must code their claims to the highest level of specificity in accordance with industry standard coding guidelines such as ICD-10-CM coding guidelines and reporting. When an ICD-10-CM diagnosis code has a specified laterality within the code description, the modifier that is appended to a CPT® or HCPCS code must correspond to the laterality within the ICD-10 description.

For CMS 1500 form claims processed on or after May 30, 2024, Anthem will apply these correct coding ICD-10-CM guidelines and deny claim lines that have a laterality diagnosis submitted with a CPT or HCPCS modifier that does not correspond to the diagnosis.      

Example one:

Reported diagnosis:

E11.3593 (Type 2 diabetes mellitus with proliferative diabetic retinopathy without macular edema, bilateral)

Billed CPT code:

67228-RT Treatment of extensive or progressive retinopathy (e.g., diabetic retinopathy), photocoagulation.

Determination:

It is not appropriate to report an RT modifier when the laterality of bilateral is identified in the ICD-10 diagnosis. Therefore, the claim line will be denied.

Example two:

Reported diagnosis

S91.011A (Laceration without foreign body, right ankle, initial encounter)

Billed CPT code:

27786-LT (Closed treatment of distal fibular fracture: lateral malleolus; without manipulation)

Determination:

It is not appropriate to report an LT modifier when the laterality of right is identified in the ICD-10 diagnosis. Therefore, the claim lime will be denied.

Additionally, the ICD-10-CM diagnosis code should correspond to the medical record, CPT, HCPCS code(s), and/or modifiers billed.

Anthem will continue to enhance its editing system to automate edits and simplify remittance messaging supported by correct coding guidelines. The enhanced editing automation will promote faster claim processing and reduce follow-up audits and/or record requests for claims not consistent with correct coding guidelines.

Diagnosis codes with a specified laterality description should be submitted with the appropriate modifier of specificity and procedure code. Ex Code: 00W19

If you have questions about this communication or need assistance, contact your provider relationship management associate.

We’re committed to active involvement with our care provider partners and going beyond the contract to create a real impact on the health of our communities.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-053055-24

Digital SolutionsCommercialMedicare AdvantageMedicaidMay 1, 2024

Roster automation update

Roster Automation is our technology solution designed to streamline and automate provider data additions, changes, and terminations that are submitted using a standardized Microsoft Excel template.

On March 29, we introduced a new Roster Automation functionality on the Upload Roster File page of Availity PDM. With this enhancement, you can view:

  • Date received and status of rosters submitted in the last 12 months.
  • Errors in submitted rosters that result in the need of manual intervention to process. The types of issues included in the error report will be incorrectly formatted data and required data elements that are missing from the roster.

Understanding the errors made when completing a roster allows you to ensure subsequent submissions do not contain those issues. Error-free rosters reduce the need for manual intervention, which improves data accuracy and processing time.

As you learn how to use the information available in the new error reports, we will continue to correct issues on your behalf.

In the future, you will need to correct any errors submitted in a roster (for example, missing data, incorrectly formatted data). Rows in a roster that contain an error will not be processed and the addition, change, or termination will not be updated in our systems. More information about when you will need to correct errors, and how to do so, will be sent in future communications and covered in future virtual webinars.

Utilize the Roster Submission Guide

Find it online: On Availity.com > Payer Spaces > Select Payer Tile > Resources > Roster Submission Guide using Provider Data Management.

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-ALL-CDCRCM-057944-24-CPN57211

Digital SolutionsCommercialApril 23, 2024

Overview of the Preference Center on Availity Essentials

In our previous communications about the Authorizations and Referrals application on Availity Essentials, we mentioned the Preference Center where you can select your preferred method of communication for authorization cases. Below, find details on how to easily access the Preference Center and set your communication preference. The Preference Center, which can be accessed by your Availity administrator or their assistant, will be available on Availity Essentials within Payer Spaces by the end of April 2024.

Access the Preference Center

After logging in to Availity Essentials, your Availity administrator, or their assistant, will select Payer Spaces from the top menu bar, then select the Anthem payer tile. Once in Payer Spaces, select the Preference Center application tile. The Preference Center will prompt them to select your organization.

Set your preferred communication mode for authorization cases

After selecting your organization, select the preference option for Authorization and Referrals to see the preferred communication mode for authorization cases and adjust the preference (Digital Access (Default) or Digital + Mail) based on your business needs.

Once in the preference setting for Authorizations and Referrals, all tax IDs and NPIs for your organization registered with Availity Essentials will be displayed on the screen. The default communication mode for authorization cases will be set to Digital Access for all organizations, including all combinations of tax IDs and NPIs.

You can change the mode of communication to Digital + Mail for any combination of tax ID and NPI. There is no need to manually enter the tax IDs and/or NPIs to set this preference. Instead, use the search bar to focus on the tax IDs and NPIs you want to make changes to. Additionally, you can add more NPIs to your current registration and set the preferred communication mode for the new NPIs under the selected tax IDs.

Manage preferences (Availity administrators)

Availity administrators can learn more about managing preferences related to Authorization Decision letters in the Custom Learning Center, available in Payer Spaces on Availity Essentials.

After logging in to Availity Essentials, select Payer Spaces from the top menu bar, then select the Anthem payer tile. Once in Payer Spaces, select the Custom Learning Center application, then select the Resources section to view or download the Reference Guide on managing receipt of Authorization Decision letters.

Through our shared health vision, we can affect real change.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-056476-24

Digital SolutionsCommercialMedicare AdvantageApril 15, 2024

Coming soon — Submit behavioral health authorizations through the Authorization application on Availity

Soon, you will be able to submit all your authorizations in one application on Availity.com.

You may already be submitting your physical health authorizations through the Availity Essentials multi-payer Authorization application — taking advantage of the time savings and speed to care through digital authorization submissions. You will soon be able to submit both your physical health and behavioral health authorizations through one Authorization application on Availity.com.

Using the Availity Authorization application to submit your behavioral health authorizations will not be much different from the process you follow today. You may enjoy more intuitive screens or learn sooner if an authorization is required, but the digital submission process is still the best way to submit your authorization requests and the fastest way to care for our members.

You will continue to use Interactive Care Reviewer (ICR) to submit an appeal or authorization for medical specialty prescriptions.

Accessing the Availity Authorization application is easy. Ask your organization’s Availity administrator to ensure you have the Authorization role assignment. Without the role assignment, you will not be able to access the Authorization application. Then, log on to Availity.com to access the app through the Patient Registration tab by selecting Authorizations and Referrals.

Training is available

Training is available for the Availity Authorization application. Once registered with the authorization role assignment, visit the training site to enroll for an upcoming live webcast or to access an on-demand recording at the Availity Authorization Training Site.

We are focused on reducing administrative burdens, so you can do what you do best — care for our members.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc., an independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-049451-23-CPN48753

Digital SolutionsMedicare AdvantageMay 1, 2024

Personalized Match update

Find Care, the doctor finder and transparency tool in the Anthem online directory, provides Anthem members with the ability to search for in-network providers using the secure member website. This tool currently offers multiple sorting options, such as sorting providers based on distance, alphabetical order, and provider name.

We previously introduced you to Personalized Match, an additional Find Care sorting option for Medicare Advantage members, which was based on provider efficiency and quality outcomes, in addition to member search radius. Personalized Match was initially limited to PCP searches and was later expanded to include certain specialists.

Beginning in June 2024 or later, we will further enhance Personalized Match. Provider availability and STARS rating scores will now more directly influence provider rankings. Additionally, provider recommendations will be driven in part by knowledge about member history derived from claims and other available clinical data. Personalized Match will continue to display providers with the highest overall ranking within the member’s search radius at the top of search results. Members may continue to sort based on distance, alphabetical order, and provider name:

  • A copy of the Personalized Match phase two methodology will be posted in Availity in the coming weeks.
  • If you have general questions regarding this new sorting option, please submit an inquiry via the web at Availity.
  • If you would like information about your quality or efficiency scoring used as part of this sorting option or if you would like to request reconsideration of those scores, you may do so by submitting an inquiry to Availity.

Anthem will continue to focus and expand our consumer tools and content to assist members in making more informed and personalized healthcare decisions. We are committed to helping patients more easily access the care they need.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-052330-24-CPN52048

Education & TrainingCommercialApril 25, 2024

Instructions for donor claim billing

Use the information below to help complete required patient information on donor claims. Correct completion of the form is needed to process the claim.

Donor claims

There are two patients involved in an organ donation — the donor and the recipient. The insurance plan for the recipient is responsible for paying the donor claim. The recipient can be the subscriber or a dependent to the subscriber (Note: Plans are instructed to include living donor charges on the recipient claims).

When billing for services rendered to the transplant donor, the care provider enters the recipient’s name, date of birth, sex, and Anthem ID number.

Completing forms

Review the information outlined below for billing instructions needed to process donor claims.

CMS-1450 (UB-04 Uniform Bill):

  • UB box 8b — recipient’s name*
  • UB box 10 — recipient’s birthdate
  • UB box 11 — recipient’s sex
  • UB box 42 — donor ICD-10-CM codes and revenue codes
  • UB box 58 — subscriber’s name
  • UB box 59 — relationship code of 39 or 40
  • UB box 60 — subscriber ID number
  • UB box 66 — donor diagnosis codes
  • UB box 80 — note this is a donor claim submission with donor’s name

CMS-1500 (Health Insurance Claim Form):

  • HCFA box 1a — subscriber’s ID number
  • HCFA box 2 — recipient’s name*
  • HCFA box 3 — recipient’s date of birth and gender
  • HCFA box 4 — subscriber’s name
  • HCFA box 6 — relationship to subscriber, other (Complete with 39 or 40.)
  • HCFA box 19 — note, this is a donor claim submission with donor’s name
  • HCFA box 21 — donor diagnosis code
  • HCFA box 53 (electronic claim) — will list the donor’s name:
  • Example: Claim note ref code: ADD Claim note Text: 39-Jones, Sally

* The recommendation is that the recipient’s name be billed. However, the care provider can bill with the donor’s name. If the claim is billed with the recipient’s name, it has a better chance at adjudication upon initial submission.

We are focused on reducing administrative burdens, so you can do what you do best — care for our members.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-056555-24-CPN54528

Education & TrainingCommercialMedicare AdvantageMay 1, 2024

Rotary to ground educational message

When determining transportation to an alternative hospital and to help avoid medical necessity denials for rotary wing air ambulance transports to another hospital, please remember the criteria below.

The use of air and water ambulance services is considered medically necessary when all the following criteria are met:

  1. The ambulance must have the necessary equipment and supplies to address the needs of the individual; and
  2. The individual’s condition must be such that any form of transportation other than by ambulance would be medically contraindicated; and
  3. The individual’s condition is such that the time needed to transport by land poses a threat to the individual’s survival or seriously endangers the individual’s health*; or the individual’s location is such that accessibility is only feasible by air or water transportation; and
  4. There is a medical condition that is life threatening, or first responders deem to be life threatening, including, but not limited to, the following:
    1. Intracranial bleeding; or
    2. Cardiogenic shock; or
    3. Major burns requiring immediate treatment in a burn center; or
    4. Conditions requiring immediate treatment in a hyperbaric oxygen unit; or
    5. Multiple severe injuries; or
    6. Transplants; or
    7. Limb-threatening trauma; or
    8. High risk pregnancy; or
    9. Acute myocardial infarction; if this would enable the individual to receive a more timely medically necessary intervention (such as percutaneous transluminal coronary angioplasty [PTCA] or fibrinolytic therapy).

* Air transportation may be appropriate if the time between identification of the need for transportation until arrival at the intended destination for ground ambulance would be at least 30 minutes longer than air transport.

For additional details on Clinical UM Guideline CG-ANC-04 Ambulance Services: Air and Ground please visit the Anthem provider site.

Clinical UM guidelines are subject to change. Administrative services only (ASO) accounts may utilize alternate criteria. All terms and conditions of the member’s benefit plan apply.

For more information please contact Provider Services.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc., an independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CRCM-052117-24-CPN51828

Education & TrainingMedicaidMarch 31, 2023

Ready, set, renew!

It’s time for some of your patients to renew their Medicaid benefits. As states begin to recommence Medicaid renewals, we want to ensure you have the information needed to help your Medicaid patients renew their healthcare coverage. Some patients have never had to renew their coverage at all, while other patients may have forgotten the process entirely.

We’re here to help.

What steps do my patients need to take?

  • Ready: Patient gets their documents ready.
  • Set: Patient ensures their form is all set
  • Renew: Patient sends renewal form via:
    • Web: ky.gov
    • Phone: 855-306-8959
    • Mail: Send to your local Department of Community Based Services office.

What if I need assistance?

Availity Chat with Payer is available during normal business hours. Get answers to your questions about eligibility, benefits, authorizations, claims status, and more. To access Availity Essentials, go to availity.com, and select the appropriate payer space tile from the drop-down. Then, select Chat with Payer and complete the pre-chat form to start your chat.

For additional support, visit the Contact Us section at the bottom of our provider website for the appropriate contact.

Availity, LLC is an independent company providing administrative support services on behalf of the health plan.

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CD-017954-22, CPN16407, KYBCBS-CD-047501-23-CPN047298, KYBCBS-CD-056721-24-CPN56608

Medical Policy & Clinical GuidelinesMedicaidApril 1, 2024

Clinical Criteria updates — December 2023

Summary: On December 11, 2023, and January 5, 2024, the Pharmacy and Therapeutic (P&T) Committee approved the following Clinical Criteria applicable to the medical drug benefit for Anthem. These policies were developed, revised, or reviewed to support clinical coding edits.

Visit Clinical Criteria to search for specific policies. If you have questions or need additional information, use this email.

Please see the explanation/definition for each category of Clinical Criteria below:

  • New: newly published criteria
  • Revised: addition or removal of medical necessity requirements, new document number
  • Updates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive

Please share this notice with other providers in your practice and office staff.

Please note:

  • The Clinical Criteria listed below applies only to the medical drug benefits contained within the member’s medical policy. This does not apply to pharmacy services.
  • This notice is meant to inform the provider of new or revised criteria that has been adopted by Anthem only. It does not include details regarding any authorization requirements. Authorization rules are communicated via a separate notice.

Effective date

Clinical Criteria number

Clinical Criteria title

New or revised

May 3, 2024

*CC-0255

Loqtorzi (toripalimab-tpzi)

New

May 3, 2024

*CC-0256

Rivfloza (nedosiran)

New

May 3, 2024

*CC-0257

Wainua (eplontersen)

New

May 3, 2024

*CC-0185

Oxlumo (lumasiran)

Revised

May 3, 2024

*CC-0107

Bevacizumab for Non-ophthalmologic Indications

Revised

May 3, 2024

*CC-0002

Colony Stimulating Factor Agents

Revised

May 3, 2024

CC-0075

Rituximab Agents for Non-Oncologic Indications

Revised

May 3, 2024

CC-0213

Voxzogo (vosoritide)

Revised

May 3, 2024

CC-0124

Keytruda (pembrolizumab)

Revised

May 3, 2024

*CC-0110

Perjeta (pertuzumab)

Revised

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CD-051283-24-CPN50531

Reimbursement PoliciesCommercialApril 3, 2024

Reimbursement policy update: Laboratory and Venipuncture Services — Professional and Facility

In the March 2024 edition of Provider News, we announced that language was inadvertently removed from the Modifier 26 comment in Section II. The policy has been updated to include the following statement:

  • When a professional provider has reported modifier 26 to procedure codes designated with NPFSRVF PC/TC indicators 3 or 9, the procedure will not be eligible for reimbursement. 

Upon further review, no claims were impacted by this omission. If you believe a claim reimbursement decision should be reviewed, please follow the normal claims dispute process outlined in the provider manual.

 

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-054401-24

Products & ProgramsMedicaidMay 1, 2024

Bringing whole person care to sickle cell disease management

Call to action

We’re committed to active involvement with our care provider partners and going beyond the contract to create a real impact on the health of our communities. We are excited to share a new and improved way to care for people living with sickle cell disease (SCD). Anthem has created a comprehensive SCD care management program. The program partners with members and care providers to remove barriers to care, improve and facilitate treatment adherence, and increase the quality of life for people living with SCD. By focusing on the prevention of SCD complications and building strategies for effective pain management, we aim to reduce preventable emergency department (ED) utilization and hospital admissions.

Our goal is to ensure that members with SCD receive comprehensive whole person care that goes beyond treating disease symptoms. Through this program, we will provide disease education, medication adherence monitoring, care coordination, as well as connections to community resources that support social drivers of health and other critical services. By building trusting relationships between Anthem, our members, care providers, and community resources, we assist our members in achieving the best quality of life possible.

To refer a Medicaid-enrolled member to the SCD Care Coordination program, call Provider Services at 855-661-2028.

Why this is important

SCD is a chronic condition and is the most common inherited red blood cell disorder in the United States affecting at least 100,000 Americans.1 The Center for Disease Control and Prevention (CDC) reports that SCD affects one out of every 365 Black and African American births and one out of every 16,300 Hispanic and Latinx births.1

Most care providers are familiar with the unpredictable symptoms and long-term morbidities that individuals affected by SCD experience, including pain and vaso-occlusive crises, depression, and fatigue. Repeated vaso-occlusion, infarction, and chronic hemolytic anemia lead to organ dysfunction. More than half of people living with SCD have some organ disease and at least 24% have damage affecting multiple organs2. Vaso-occlusive events can have devastating consequences across all age groups. For example, it is estimated that 50% of people with SCD will experience cerebral vasculopathy by age 14, and 25% of adults with SCD will experience a stroke by age 45.2

Care providers might lose sight of the high medical costs (estimated to be over $1 million per individual lifetime)6,1, barriers to care, and reduced quality of life people with SCD face. Despite medical advances in treatments, such as medications and gene therapy, large discrepancies in both outcomes and mortality rates for people with SCD still remain. One startling national statistic shows that life expectancy for people with SCD is at least 22 years lower than that for people without SCD.6 These gaps can be attributed to multiple factors including limited access to comprehensive care.

The effects of SCD on quality of life are often unrecognized. Patients with SCD are more likely than people without SCD to have lost workdays and missed school days because of time spent in the hospital or ED.6 The prevalence of depression and anxiety among people with SCD is five times greater than that of the general population.2

Patient experience is linked to their perceptions of quality of care.10 Many people living with SCD report dissatisfaction with the quality of care they receive. Contributing factors to this dissatisfaction include perceptions of racial discrimination, feelings of being stereotyped as drug seekers who do not have legitimate pain, barriers to accessing specialty care, and lack of clinician comfort with disease management — especially pain.10

The presence of implicit racial bias in healthcare and perceptions of discrimination are directly linked to negative health experiences.2 One example comes from a published study that showed people with sickle cell crisis in the ED waited 50% longer for pain treatment than patients who arrived with long bone fractures.3 In another study of ED wait times, patients with SCD waited an average of two hours longer for initial pain treatment compared to patients without SCD.3

Negative healthcare experiences lead to feelings of mistrust, which result in poor health outcomes. Patients with SCD who report experiences of discrimination are 53% more likely to report nonadherence to physician treatment recommendations.10 The lack of trusting relationships with healthcare providers correlates to low patient self-efficacy. This is compounded by obstacles related to social drivers of health, which disproportionately affect many individuals living with SCD.

We designed this program in our pursuit to deliver the most comprehensive care, and we believe it can foster close collaboration between Anthem and healthcare providers. This joint effort has the potential to address and eliminate the challenges our members with sickle cell disease currently face.

To support this endeavor, Anthem is ready to provide essential tools and resources needed to make a positive impact. Our shared commitment can help enhance the healthcare journey for our members.

References:

  1. American Society of Hematology. (2022). The cost of living with sickle cell disease. tinyurl.com/2ezzzwzt.
  2. BlueBirdBio. (n.d.). We can change SCD. changeforscd.com
  3. Hutchinson S. (2023). For people with sickle cell disease, ERs can mean life-threatening waits. tinyurl.com/2fy2n5mb
  4. Jang T, Poplawska M, et al. (2021). Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events. Journal of Translational Medicine. 10.1186/s12967-021-03074-z
  5. Johnson KM, Boshen J, et al. (2023). Lifetime medical costs attributable to sickle cell disease among nonelderly individuals with commercial insurance. Blood Advances, 7(3). tinyurl.com/2phs7hcy
  6. Lubeck D, Agodoa I, Bhakta N, et al. (2019) Estimated life expectancy and income of patients with sickle cell disease compared with those without sickle cell disease. JAMA Network Open. tinyurl.com/5n8wyfrw
  7. Mainous AG, Tanner RJ, et al. (2015) Attitudes toward management of sickle cell disease and its complications: A national survey of academic family physicians. Anemia. Article ID 853835. tinyurl.com/2s5nwax9
  8. National Institutes of Health. (2022). Researchers identify the high costs of living with sickle cell disease. tinyurl.com/3mw6spxc
  9. Onimoe G, Rotz S. (2020) Sickle cell disease: a primary care update. 87(1) 19-27 ccjm.org/content/87/1/19
  10. Oyedeji C, Strouse J. Improving the quality of care for adolescents and adults with sickle cell disease – it’s a long road. JAMA Network Open. 2020;3(5) tinyurl.com/4464y44y
  11. United States, Department of Health and Human Services, Centers for Disease Control and Prevention. (7 July 2023). Are family physicians comfortable treating people with sickle cell disease? Centers for Disease Control and Prevention. tinyurl.com/yhr4tyb7
  12. Wachnik, AA, Welch-Coltrane, JL, Adams, MC, et al. (2022) A standardized emergency department order set decreases admission rates and in-patient length of stay for adult patients with sickle cell disease. Pain Medicine. doi.org/10.1093/pm/pnac096

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CD-051228-24-CPN50704

Federal Employee Program (FEP)CommercialMay 1, 2024

HEDIS tips: Adult Immunization Status (AIS-E)

HEDIS® is a widely used set of performance measures developed and maintained by NCQA. These are used to drive improvement efforts surrounding best practices.

What vaccines are included in the HEDIS Adult Immunization Status (AIS-E) measure?

Influenza: The percentage of members 19 years of age and older who are up to date on recommended routine vaccines for influenza.

Td/Tdap: The percentage of members 19 years of age and older who are up to date on recommended routine vaccines for tetanus and diphtheria (Td) or tetanus, diphtheria, and acellular pertussis (Tdap).

Zoster: The percentage of members 50 years of age and older who are up to date on recommended routine vaccines for zoster.

Pneumococcal: The percentage of members 66 years of age and older who are up to date on recommended routine vaccines for pneumococcal.

Using correct codes can help your practice improve HEDIS AIS-E results.

Using the correct code to capture the vaccine given, or identifying anaphylaxis code to reflect the contraindications, can help your practice with performance rates.

Adult immunization

Immunization description

CPT® codes

HCPCS

CVX

Influenza immunization

90630, 90653, 90654, 90655, 90656, 90657, 90658, 90660*, 90661, 90662, 90672*, 90673, 90674, 90682, 90685, 90686, 90687, 90688, 90689, 90694, 90756

G0008

88, 135, 140, 141,144, 150, 150, 153, 155, 158, 166, 168, 168, 171, 185, 186, 197, 205

Td/Tdap

90714, 90715

09, 113, 115, 138, 139

Zoster immunization

90736, 90750

121, 187

Pneumococcal immunization

90670, 90671, 90677, 90732

G0009

33, 109, 133, 152, 215, 216

* Influenza live virus

Sources: 1. NCQA Health Plan Description AND ECDS: Adult Immunization Status, pages 643 to 650.
2. HEDIS MY 2024 Volume 2 Value Set Directory 2023-08-01: tabs Measures to Value Sets and Value Sets to Codes.

Exclusions:

  • Members who use hospice services; or
  • Members who elect to use a hospice benefit any time during the measurement period; or
  • Members who die any time during the measurement period.
  • Members with a history of at least one of the following contraindications any time during the measurement period.

Exclusions codes for anaphylaxis

Immunization description

SNOMED CT

edition USA codes

Description

Influenza immunization

  • 47136000124100

  • Anaphylaxis due to the influenza vaccine any time before or during the measurement period

Td/Tdap

  • 428281000124107

  • 428291000124105

  • 192710009

  • 192711008

  • 192712001

Members with a history of at least one of the following contraindications any time before or during the measurement period:

  • Anaphylaxis due to diphtheria, tetanus, or pertussis vaccine (caused by diphtheria and tetanus)
  • Anaphylaxis due to diphtheria, tetanus, or pertussis vaccine (caused by tetanus, diphtheria and acellular pertussis)
  • Encephalitis due to diphtheria, tetanus, or pertussis vaccine (post tetanus vaccination)
  • Encephalitis due to diphtheria, tetanus, or pertussis vaccine (post diphtheria vaccination)
  • Encephalitis due to diphtheria, tetanus, or pertussis vaccine (post pertussis vaccination)

Zoster immunization

  • 471381000124105

Members with anaphylaxis due to the herpes zoster vaccine any time before or during the measurement period

Pneumococcal immunization

  • 471141000124102

Members with anaphylaxis due to the pneumococcal vaccine any time before or during the measurement period

Helpful tips

Immunization information obtained from the medical record:

  • A note indicating the name of the specific antigen and the date of the immunization.
  • A certificate of immunization prepared by an authorized healthcare provider or agency, including the specific dates and types of immunization administered.
  • Document in the medical record of refusal or anaphylaxis reaction to the serum/vaccination.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-054689-24-CPN54510

PharmacyCommercialApril 24, 2024

Specialty pharmacy updates — May 2024

Prior authorization clinical review of non-oncology use of specialty pharmacy drugs is managed by the Medical Specialty Drug Review team of Anthem. Review of specialty pharmacy drugs for oncology use is managed by Carelon Medical Benefits Management, Inc.

Important to note: Currently, your patients may be receiving these medications without prior authorization. As of the effective date below, you may be required to request prior authorization review for your patients’ continued use of these medications.

Inclusion of a national drug code (NDC) code on your claim will help expedite claim processing of drugs billed with a not otherwise classified (NOC) code.

Prior authorization updates

Effective for dates of service on and after August 1, 2024, the following specialty pharmacy codes from current or new Clinical Criteria documents will be included in our prior authorization review process.

Access our Clinical Criteria here view the complete information for these prior authorization updates.

Clinical Criteria

Drug

HCPCS or CPT® code(s)

CC-0259

Amtagvi (lifleucel)

J3490, J3590

CC-0258

iDoseTR (travoprost Implant)

J3490, J3590

CC-0260

Nexobrid (anacaulase-bcdb)

J7353

Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity.

Quantity limit updates

Effective for dates of service on and after August 1, 2024, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our quantity limit review process.

Access our Clinical Criteria here view the complete information for these quantity limit updates.

Clinical Criteria

Drug

HCPCS or CPT code(s)

CC-0064

Arcalyst (rilonacept)

J2793

CC-0139

Evenity (romosozumab-aqqg)

J3111

CC-0258

iDoseTR (travoprost Implant)

J3490, J3590

CC-0064

Interleukin-1 Inhibitors (Ilaris)

J0638

CC-0057

Krystexxa (pegloticase)

J2507

CC-0260

Nexobrid (anacaulase-bcdb)

J7353

CC-0068

Genotropin, Humatrope, Norditropin, Nutropin, Omnitrope, Saizen, Saizenprep, Serostim, Zomacton, Zorbtive (somatropin drugs)

J2941

CC-0047

Trogarzo (ibalizumab-uiyk)

J1746

CC-0067

Tyvaso (treprostinil)

J7686

CC-0067

Ventavis (Iloprost)

Q4074

Site of care updates

Effective for dates of service on and after August 1, 2024, the following specialty pharmacy codes from current or new clinical criteria documents will be included in our site of care review process.

Access our Clinical Criteria here view the complete information for these site of care updates.

Clinical Criteria

Drug

HCPCS or CPT code(s)

CC-0252

Adzynma (ADAMTS13, recombinant-krhn)

C9167

CC-0001

Aranesp (darbepoetin alfa)

J0881

CC-0034

Berinert (c1 esterase inhibitor (human))

J0597

CC-0042

Bimzelx (bimekizumab-bkzx)

C9399, J3590

CC-0042

Cosentyx (secukinumab)

C9399, J3490, J3590

CC-0061

Eligard, Lupron Depot (leuprolide acetate)

J9217

CC-0001

Epogen, Procrit (epoetin alfa)

J0885

CC-0034

Kalbitor (ecallantide)

J1290

CC-0228

Leqembi (lecanemab)

J0174

CC-0061

Leuprolide Acetate Depot (Cipla) (leuprolide acetate)

J1954

CC-0061

Lupron Depot (leuprolide acetate)

J1950

CC-0111

Nplate (romiplostim)

J2796

CC-0050

Omvoh (mirikizumab-mrkz)

C9168

CC-0018

Pombiliti (cipaglucosidase alfa-atga)

J1203

CC-0001

Retacrit (epoetin alfa-epbx)

Q5106

CC-0235

Revcovi (elapegademase-lvlr)

C9399, J3590

CC-0256

Rivfloza (nedosiran)

J3490

CC-0034

Ruconest (recombinant c1esterase inhibitor)

J0596

CC-0203

Ryplazim (plasminogen, human-tvmh)

J2998

CC-0058

Sandostatin (octreotide)

J2354

CC-0058

Sandostatin LAR Depot (octreotide)

J2353

CC-0236

Signifor LAR (pasireotide)

J2502

CC-0066

Tofidence (tocilizumab-bavi)

Q5133

CC-0020

Tyruko (natalizumab-sztn)

Q5134

CC-0250

Veopoz (pozelimab-bbfg)

J9376

CC-0257

Wainua (eplontersen)

C9399, J3490

CC-0254

Zilbrysq (zilucoplan)

J3490

CC-0062

Zymfentra (infliximab-dyyb)

J3590


Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-055424-24-CPN54800

PharmacyMedicaidApril 5, 2024

Prior authorization updates for medications billed under the medical benefit

Effective June 1, 2024, the following medication codes will require prior authorization.

Please note, inclusion of a National Drug Code (NDC) on your medical claim is necessary for claims processing.

Visit the Clinical Criteria website to search for the specific Clinical Criteria listed below.

Clinical Criteria

HCPCS or CPT® code(s)

Drug name

CC-0062

J3490, J3590

Yuflyma (adalimumab-aaty)

What if I need assistance?

If you have questions about this communication or need assistance with any other item, contact your local provider relationship management representative or call Provider Services at 855-661-2028.

Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity.

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CD-047933-23-CPN47437

PharmacyMedicaidApril 9, 2024

Prior authorization updates for medications billed under the medical benefit

Effective June 1, 2024, the following medication codes will require prior authorization.

Please note, inclusion of a National Drug Code (NDC) on your medical claim is necessary for claims processing.

Visit the Clinical Criteria website to search for the specific Clinical Criteria listed below.

Clinical Criteria

HCPCS or CPT® code(s)

Drug name

CC-0241

J3490, J3590

Elfabrio (pegunigalsidase alfa-iwxj)

CC-0242

C9399, J3490, J3590, J9999

Epkinly (epcoritamab-bysp)

CC-0237

J3490, J3590

Qalsody (tofersen)

CC-0243

J3490, J3590

Vyjuvek (beremagene geperpavec)

CC-0240

J9999

Zynyz (retifanlimab-dlwr)

What if I need assistance?

If you have questions about this communication or need assistance with any other item, contact your local provider relationship management representative or call Provider Services at 855-661-2028.

Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity.

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc., independent licensee of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CD-047741-23-CPN47364

PharmacyMedicare AdvantageApril 8, 2024

Anthem expands specialty pharmacy precertification list

Effective for dates of service on and after August 1, 2024, the specialty Medicare Part B drugs listed in the table below will be included in our precertification review process.

Federal and state law, as well as state contract language and CMS guidelines — including definitions and specific contract provisions/exclusions — take precedence over these precertification rules and must be considered first when determining coverage. Noncompliance with new requirements may result in denied claims.

HCPCS or CPT® codes

Medicare Part B drugs

J9286

Columvi (glofitamab-gxbm)

C9162, J3490, J3590, J9999

Izervay (avacincaptad pegol)

J9333

Rystiggo (rozanolixizumab-noli)

J9334

Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-gvfc)

We look forward to working together to achieve improved outcomes.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-053057-24-CPN52693

PharmacyCommercialApril 9, 2024

Acquisition of Paragon Healthcare

Elevance Health, the parent company of our pharmacy benefit management partner, CarelonRx, Inc., has completed its acquisition of Paragon Healthcare, Inc., a company specializing in life-saving and life-giving infusible and injectable therapies.

Paragon Healthcare provides infusion services to members through its omnichannel model of ambulatory infusion centers, home infusion pharmacies, and other specialty pharmacy services. The company, headquartered in Plano, Texas, currently serves more than 35,000 members at over 40 ambulatory infusion centers across eight states, as well as in members’ homes.

The acquisition of Paragon Healthcare will deepen our capabilities around providing affordable, convenient access to specialty medications for those living with chronic and complex illnesses. Paragon Healthcare will operate as part of CarelonRx.

CarelonRx plans to expand Paragon Healthcare’s geographical footprint and operations while bolstering its therapeutic coverage to ensure members receive convenient, timely access to medications.

We share a health vision with our care providers that means real change for consumers.

CarelonRx, Inc. is an independent company providing pharmacy benefit management services on behalf of the health plan.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-054706-24-CPN53991

PharmacyCommercialMarch 1, 2024

Pharmacy information available on our provider website

Visit the Drug Lists page on our website at anthem.com/ms/pharmacyinformation/home.html for more information about:

  • Copayment/coinsurance requirements and their applicable drug classes.
  • Drug lists and changes.
  • Prior authorization criteria.
  • Procedures for generic substitution.
  • Therapeutic interchange.
  • Step therapy or other management methods subject to prescribing decisions.
  • Any other requirements, restrictions, or limitations that apply to using certain drugs.

The commercial and exchange drug lists are posted to the website quarterly on the first day of the month in January, April, July, and October.

To locate the exchange, select Formulary and Pharmacy Information and scroll down to Select Drug Lists. This drug list is also reviewed and updated regularly as needed.

Federal Employee Program pharmacy updates and other pharmacy related information may be accessed at fepblue.org > Pharmacy Benefits.

Please call provider services to request a copy of the pharmaceutical information available online if you do not have internet access.

Through our efforts, we are committed to reducing administrative burden because we value you, our care provider partner.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CM-050732-24-CPN50598, MULTI-BCBS-CM-053029-24-CPN53029

PharmacyMedicare AdvantageApril 5, 2024

CarelonRx, Inc. Mail changed to CarelonRx Pharmacy on January 1, 2024

CarelonRx mail service pharmacy changed to CarelonRx Pharmacy on January 1, 2024.

This pharmacy change does not affect the way CarelonRx works with care providers. There are no changes to the prior authorization process, how claims are processed, or level of support.

This change does not impact your patients’ benefits, coverage, or how their medications are filled.

When e-prescribing orders to the mail service pharmacy:

Prescribers will need to choose CarelonRx Pharmacy, not CarelonRx Mail, if searching by name. If searching by NPI (National Provider Identifier), the NPI is changing to 1568179489.

We are taking steps to ensure a smooth transition to our new home delivery pharmacy for your patients:

  • Patients will receive a letter to alert them of their new pharmacy.
  • If a patient has refills left, we will move them to CarelonRx Pharmacy, and we’ll also transfer auto refills.
  • If a patient does not have any refills left of their medication(s), CarelonRx Pharmacy will contact you to obtain a new prescription.
  • If a patient is taking a controlled substance, CarelonRx Pharmacy will contact you to obtain a new prescription.
  • All prior authorizations will be transitioned to CarelonRx Pharmacy.

CarelonRx Pharmacy delivers an enhanced, digital-first solution to your patients to improve adherence and lower costs, while removing barriers associated with traditional retail and mail order pharmacy models. Some highlights include:

  • 24/7 text or chat (digitally) directly with our pharmacists at any time.
  • Enhanced end-to-end order status tracking from prescription order to delivery.
  • Free delivery of their 90-day supply, directly to a patient’s door.

CarelonRx, Inc. is an independent company providing pharmacy benefit management services on behalf of the health plan.

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BCBS-CR-045499-23-CPN45113

Quality ManagementCommercialMedicaidApril 15, 2024

Cervical Cancer Screening (CCS) and Prenatal and Postpartum Care (PPC) for HEDIS

HEDIS® (Healthcare Effectiveness Data Information Set) is a widely used set of performance measures developed and maintained by NCQA (National Committee for Quality Assurance). These are used to drive improvement efforts surrounding best practices.

HEDIS 2024 Documentation for Cervical Cancer Screening (CCS)

Measure description: The percentage of women 21 to 64 years of age who were screened for cervical cancer using either of the following criteria:

  • Women 21 to 64 years of age who had cervical cytology performed within the last 3 years.
  • Women 30 to 64 years of age who had cervical high-risk human papillomavirus (hrHPV) testing performed within the last 5 years.
  • Women 30 to 64 years of age who had cervical cytology/high-risk human papillomavirus (hrHPV) co-testing within the last 5 years.

What we are looking for in provider records:

  • Documentation in the medical record indicating the date when the cervical cytology was performed and result or finding (2022 to 2024)
  • Documentation in the medical record indicating the date when the hrHPV test was performed and result or finding (2020 to 2024)
    • Documentation of HPV test can be counted as hrHPV testing along with result or finding
  • Documentation of complete, total, or radical hysterectomy (abdominal, vaginal, or unspecified anytime in the member’s history through 12/31/2024).
  • Documentation of vaginal hysterectomy (anytime in the member’s history through 12/31/2024).
  • Evidence of hospice services in 2024
  • Evidence patient expired in 2024

Please note: Documentation of hysterectomy alone does not meet the criteria, because it is not sufficient evidence that the cervix was removed.

Helpful Hints:

  • Educate patient on importance of regular cervical cancer screening.
  • OB/GYN and PCP should share cervical cancer screening results.
  • Document date and result of member reported cervical cancer or HPV screenings.

HEDIS 2024 Documentation for Prenatal and Postpartum Care (PPC)

Measure description: The percentage of deliveries of live births on or between October 8 of the year prior to the measurement year (2023) and October 7 of the measurement year (2024). For these women, the measure assesses the following facets of prenatal and postpartum care.

  • Timeliness of Prenatal Care. The percentage of deliveries that received a prenatal care visit in the first trimester or within 42 days of enrollment with the Healthy Blue plan.
  • Postpartum Care. A postpartum visit on or between 7 and 84 days after delivery.

What we are looking for in provider records for a prenatal care visit with a PCP or OB/GYN or other prenatal practitioner:

  • Documentation in the medical record for deliveries of live births on or between October 8 of the year prior to the measurement year (2023) and October 7 of the measurement year (2024) must include a note indicating the date when the prenatal care visit occurred and evidence of one of the following:
    • Documentation indicating the woman is pregnant or references to the pregnancy for example:
      • Documentation in a standardized prenatal flow sheet
      • Documentation of LMP, EDD, or gestational age
      • Documentation of a positive pregnancy test result
      • Documentation of gravidity and parity
      • Documentation of complete obstetrical history
      • Documentation of prenatal risk assessment and counseling/education
    • Documentation of a basic physical obstetrical examination that includes auscultation for fetal heart tone, or pelvic exam with obstetric observations, or measurement of fundus height (a standardized prenatal flow sheet may be used).
    • Evidence that a prenatal care procedure was performed such as:
      • Screening test in the form of an obstetrical panel (must include all the following: hematocrit, differential WBC count, platelet count, hepatitis B surface antigen, rubella antibody, syphilis test, RBC antibody screen, Rh and ABO blood typing)
      • Torch antibody panel alone
      • A rubella antibody test/titer with an Rh incompatibility (ABO/blood typing)
    • Ultrasound of a pregnant uterus
    • Evidence of nonlive birth
    • Evidence of hospice services in 2024
    • Evidence patient expired in 2024

What We Are Looking For In Provider Records For A Postpartum Care Visit With A PCP Or OB/GYN or other prenatal practitioner:

  • Documentation in the medical record must include a note indicating the date when a postpartum visit occurred and one of the following:
    • Pelvic exam
    • Evaluation of weight, BP, breasts, and abdomen
    • Notation of postpartum care
    • Perineal or cesarean incision/wound check
    • Screening for depression, anxiety, tobacco use, substance use disorder, or preexisting mental health disorders
    • Glucose screening for women with gestational diabetes
    • Documentation of any of the following: Infant care or breastfeeding, resumption of intercourse, birth spacing or family planning, sleep/fatigue, resumption of physical activity, attainment of healthy weight
  • Evidence of nonlive birth
  • Evidence of hospice services in 2024
  • Evidence patient expired in 2024

Helpful Hints:

  • Educate members on the importance of timely prenatal care.
  • Schedule postpartum visit during final prenatal appointment or prior to discharge from hospital.
  • Reach out to members to remind them of scheduled prenatal and postpartum appointments.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CDCM-048361-23-CPN48274

Quality ManagementCommercialMedicare AdvantageMedicaidMay 1, 2024

HEDIS 2024 documentation for Controlling High Blood Pressure (CBP) and Statin Therapy for Patients with Cardiovascular Disease (SPC)

HEDIS 2024 documentation for Controlling High Blood Pressure (CBP)

HEDIS® (Healthcare Effectiveness Data Information Set) is a widely used set of performance measures developed and maintained by NCQA. These are used to drive improvement efforts surrounding best practices.

Measure description: The percentage of members 18 to 85 years of age who had a diagnosis of hypertension (HTN) and whose BP (blood pressure) was adequately controlled (< 140/90 mm Hg) during the measurement year.

What we are looking for in provider records:

  • Last BP documented in 2024 regardless of reading

Documentation below could be used to exclude the patient:

  • Evidence of hospice or palliative services in 2024
  • Evidence patient expired in 2024
  • Documentation of pregnancy any time during 2024
  • Documentation of end stage renal disease, dialysis, nephrectomy, or kidney transplant any time in the member’s history on or prior to December 31, 2024

Helpful hints:

  • Take BP at every visit.
  • Take a second BP before the end of the office visit if the BP was ≥ 140/90.
  • Counsel on healthy habits for managing high blood pressure.
  • BPs cannot be taken:
  • On the same day as a diagnostic test or diagnostic or therapeutic procedure that requires a change in diet or change in medication on or one day before the day of the test or procedure, with the exception of fasting blood tests.
  • From member-reported BPs if taken with a non-digital device such as with a manual blood pressure cuff and a stethoscope.

HEDIS 2024 documentation for Statin Therapy for Patients with Cardiovascular Disease (SPC)

Measure description: The percentage of males 21 to 75 years of age and females 40 to 75 years of age during the measurement year who were identified as having clinical atherosclerotic cardiovascular disease (ASCVD) and received statin therapy and remained on the statin for at least 80% of the treatment period.

What we are looking for in provider records

Documentation in the medical record indicating the date the patient was dispensed at least one high-intensity or moderate-intensity statin medication during the measurement year.

All of the following must be present with a dispensed medication:

  • Name of the drug (generic or brand name)
  • Strength/dose
  • Route
  • Date when the medication was dispensed, filled, or shipped to the patient

Documentation below could be used to exclude the patient:

  • Evidence of hospice services in 2024
  • Evidence patient expired in 2024
  • Evidence patient received palliative care in 2024
  • Evidence patient was pregnant or underwent IVF treatment in 2023 or 2024
  • Evidence of ESRD or dialysis in 2023 or 2024
  • Evidence of cirrhosis in 2023 or 2024
  • Evidence of a dispensed prescription for Clomiphene in 2023 or 2024
  • History of myalgia, myositis, myopathy, muscle pain or rhabdomyolysis documented in 2024

Helpful hints:

  • Recommended that if the patient has a reaction to statins, record the specific reaction (myalgia, myositis, myopathy, muscle pain or rhabdomyolysis) in the patient’s chart annually.
  • Recommended to also include drug quantity and directions with the dispensed medication so that days’ supply can be calculated for the measure.

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA)

Anthem Blue Cross and Blue Shield Medicaid is the trade name of Anthem Kentucky Managed Care Plan, Inc. Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Kentucky, Inc. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

KYBCBS-CDCRCM-048389-23-CPN48275